Working... Menu

A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02782481
Recruitment Status : Terminated (Decision to change the study design)
First Posted : May 25, 2016
Last Update Posted : November 22, 2018
Information provided by (Responsible Party):
NeuroDerm Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 15, 2018
  Actual Study Completion Date : October 15, 2018